The present specification discloses HIV antigens, immunogenic compositions and medicaments comprising such HIV antigens, methods and uses for such HIV antigens and immunogenic compositions and medicaments for making a α-HIV antibody, as well as α-HIV antibodies, therapeutic compositions an medicaments comprising such α-HIV antibodies, and methods and uses for such α-HIV antibodies and therapeutic compositions and medicaments for treating an HIV-based disease.
